Market Cap | 2.53B | P/E | 83.02 | EPS this Y | -42.60% | Ern Qtrly Grth | 14.70% |
Income | 21.35M | Forward P/E | 46.70 | EPS next Y | 65.50% | 50D Avg Chg | -4.00% |
Sales | 322.42M | PEG | 2.69 | EPS past 5Y | 37.14% | 200D Avg Chg | -15.00% |
Dividend | N/A | Price/Book | 7.17 | EPS next 5Y | 30.00% | 52W High Chg | -53.00% |
Recommedations | 2.10 | Quick Ratio | 4.90 | Shares Outstanding | 49.13M | 52W Low Chg | 13.00% |
Insider Own | 0.51% | ROA | 4.09% | Shares Float | 37.60M | Beta | 0.88 |
Inst Own | 107.57% | ROE | 5.91% | Shares Shorted/Prior | 4.87M/5.43M | Price | 52.30 |
Gross Margin | 78.36% | Profit Margin | 6.62% | Avg. Volume | 681,254 | Target Price | 48.28 |
Oper. Margin | 15.55% | Earnings Date | May 1 | Volume | 932,762 | Change | -0.95% |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Mizuho | Buy | Apr 11, 24 |
Canaccord Genuity | Hold | Apr 8, 24 |
Needham | Hold | Apr 4, 24 |
Stifel | Buy | Apr 1, 24 |
Stifel | Buy | Mar 11, 24 |
Mizuho | Buy | Feb 28, 24 |
Piper Sandler | Neutral | Feb 27, 24 |
Needham | Hold | Dec 5, 23 |
Morgan Stanley | Equal-Weight | Dec 4, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Jan 08 | Buy | 13.55 | 4,042 | 54,769 | 10,768,430 | 01/10/24 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Jan 03 | Buy | 14.4 | 226,553 | 3,262,363 | 10,764,388 | 01/05/24 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Nov 28 | Buy | 15.86 | 434,991 | 6,898,957 | 10,537,835 | 11/30/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Nov 10 | Buy | 16.44 | 34,827 | 572,556 | 10,102,844 | 11/14/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Nov 07 | Buy | 16.8 | 289,140 | 4,857,552 | 10,068,017 | 11/09/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Nov 02 | Buy | 17.74 | 309,154 | 5,484,392 | 9,778,877 | 11/06/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Oct 04 | Buy | 18.91 | 205,296 | 3,882,147 | 9,469,723 | 10/06/23 |
Lin Elizabeth Yeu | Director Director | Sep 21 | Buy | 40.00 | 2,500 | 100,000 | 2,855 | 09/22/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Sep 19 | Buy | 20.2 | 291,383 | 5,885,937 | 9,264,427 | 09/21/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Sep 05 | Buy | 20.76 | 189,962 | 3,943,611 | 8,973,044 | 09/07/23 |
FARRELL STEPHEN C | Director Director | Jun 15 | Option | 0.00 | 1,709 | 8,276 | 06/16/23 | |
Kliman Gilbert H | Director Director | Jun 15 | Option | 0.00 | 3,417 | 9,656 | 06/16/23 | |
WEISNER AIMEE S | Director Director | Jun 15 | Option | 0.00 | 3,417 | 3,417 | 06/16/23 | |
Yu K Peony | Director Director | Jun 15 | Option | 0.00 | 1,709 | 2,786 | 06/16/23 | |
Michna Magda | Chief Clinical, Regu.. Chief Clinical, Regulatory, | May 08 | Option | 0.00 | 14,047 | 14,047 | 05/09/23 | |
Foust Warren | Chief Operating Offi.. Chief Operating Officer | May 08 | Option | 0.00 | 20,331 | 20,331 | 05/09/23 | |
Studholme Robert | Senior VP, Operation.. Senior VP, Operations | Mar 10 | Option | 0.00 | 8,859 | 31,980 | 03/10/23 | |
Williams Patrick F. | Chief Financial Offi.. Chief Financial Officer | Mar 07 | Option | 58.13 | 1,711 | 99,460 | 35,492 | 03/08/23 |
Studholme Robert | Senior VP, Operation.. Senior VP, Operations | Mar 07 | Option | 58.13 | 1,709 | 99,344 | 23,121 | 03/08/23 |
Holliday Keith | Chief Technology Off.. Chief Technology Officer | Mar 07 | Option | 58.13 | 1,431 | 83,184 | 19,979 | 03/08/23 |
Gesten Samuel J | Chief Legal Officer Chief Legal Officer | Mar 07 | Option | 58.13 | 1,338 | 77,778 | 35,306 | 03/08/23 |
Francese James E | Sr. VP, Comm. Ops.,.. Sr. VP, Comm. Ops., NA, APAC | Mar 07 | Option | 58.13 | 1,083 | 62,955 | 35,319 | 03/08/23 |
Barnes Scott D | Chief Medical Office.. Chief Medical Officer | Mar 07 | Option | 58.13 | 1,603 | 93,182 | 32,143 | 03/08/23 |
BROADWOOD PARTNERS, L.P. | 10% Owner 10% Owner | Dec 27 | Buy | 23.8 | 191,075 | 4,547,585 | 8,783,082 | 12/29/22 |
Francese James E | Sr. VP, Comm. Ops.,.. Sr. VP, Comm. Ops., NA, APAC | Sep 27 | Sell | 75 | 35,425 | 2,656,875 | 34,908 | 09/29/22 |
Francese James E | Sr. VP, Comm. Ops.,.. Sr. VP, Comm. Ops., NA, APAC | Sep 27 | Option | 7.52 | 13,075 | 98,324 | 47,983 | 09/29/22 |
Yu K Peony | Director Director | Jun 16 | Option | 0.00 | 355 | 1,077 | 06/17/22 | |
Lin Elizabeth Yeu | Director Director | Jun 16 | Option | 0.00 | 355 | 355 | 06/17/22 | |
FARRELL STEPHEN C | Director Director | Jun 16 | Option | 0.00 | 355 | 6,567 | 06/17/22 | |
Williams Patrick F. | Chief Financial Offi.. Chief Financial Officer | Jun 07 | Option | 0.00 | 5,121 | 34,844 | 06/08/22 | |
Mason Caren L | President & CEO President & CEO | May 18 | Option | 9.3 | 105,000 | 976,500 | 118,645 | 05/20/22 |
Mason Caren L | President & CEO President & CEO | May 18 | Sell | 57.48 | 105,000 | 6,035,400 | 83,645 | 05/20/22 |
Williams Patrick F. | Chief Financial Offi.. Chief Financial Officer | Mar 07 | Option | 0.00 | 9,225 | 34,844 | 03/08/22 | |
Mason Caren L | President & CEO President & CEO | Mar 07 | Option | 0.00 | 20,269 | 83,645 | 03/08/22 | |
Holliday Keith | Chief Technology Off.. Chief Technology Officer | Mar 07 | Option | 0.00 | 7,716 | 24,437 | 03/08/22 | |
Gesten Samuel J | Chief Legal Officer Chief Legal Officer | Mar 07 | Option | 0.00 | 7,216 | 34,799 | 03/08/22 | |
Francese James E | Sr. VP, Comm. Ops.,.. Sr. VP, Comm. Ops., NA, APAC | Mar 07 | Option | 0.00 | 5,839 | 58,469 | 03/08/22 | |
Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, C.. Sr. VP, Comm. Ops, China | Mar 07 | Option | 0.00 | 5,910 | 83,110 | 03/08/22 | |
Barnes Scott D | Chief Medical Office.. Chief Medical Officer | Mar 07 | Option | 0.00 | 7,991 | 31,317 | 03/08/22 | |
Mason Caren L | President & CEO President & CEO | Nov 16 | Option | 7.76 | 105,000 | 814,800 | 98,376 | 11/18/21 |
Mason Caren L | President & CEO President & CEO | Nov 16 | Sell | 113.95 | 105,000 | 11,964,750 | 63,376 | 11/18/21 |
Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, C.. Sr. VP, Comm. Ops, China | Sep 03 | Sell | 157.56 | 54,575 | 8,598,837 | 88,722 | 09/03/21 |
Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, C.. Sr. VP, Comm. Ops, China | Sep 03 | Option | 24.52 | 34,916 | 856,140 | 106,065 | 09/03/21 |
- | - - | Jun 28 | Sell | 78.14 | 228,443 | 17,850,536 | 8,664,239 | 06/28/21 |
- | - - | Jun 15 | Sell | 73.72 | 59,550 | 4,390,026 | 9,000,357 | 06/15/21 |
Barnes Scott D | Chief Medical Office.. Chief Medical Officer | Mar 11 | Option | 27.31 | 7,333 | 200,264 | 27,723 | 03/11/21 |
- | - - | Feb 12 | Sell | 62.27 | 37,451 | 2,332,074 | 9,544,091 | 02/12/21 |
- | - - | Feb 09 | Sell | 60.41 | 257,619 | 15,562,764 | 9,581,542 | 02/09/21 |
- | - - | Jan 28 | Sell | 52.03 | 789,883 | 41,097,612 | 9,900,022 | 01/28/21 |
- | - - | Jan 12 | Sell | 44.64 | 60,000 | 2,678,400 | 10,689,905 | 01/12/21 |